Apple Plans Hypertension, Sleep Apnea Detection For Next Watch
(Bloomberg) -- Apple Inc. is planning several new health-related features for next year's Apple Watch and a paid health service, people familiar with their development said.
Bloomberg News reported on these projects for the first time in an investigation published Wednesday on Apple's evolving approach to health care. Here are the key takeaways on what's planned for the Apple Watch in 2024:
- A new sensor to detect when a person's blood pressure is elevated. The initial system won't show a user their exact systolic and diastolic measurements, but the company is working on a follow-up version for later that could. This will be coupled with a new blood pressure journal so a user can notate what was happening when hypertension occurred.
- A new system to detect sleep apnea. The Apple Watch will monitor a person's sleeping and breathing habits to predict if a person has the condition. An app will then recommend a user follow-up with a doctor.
Apple is working on a new Apple Watch for later next year with an updated design that would support the new capabilities, Bloomberg News previously reported. Apple is also working on various other new health features, including:
- New features to turn AirPods into over-the-counter hearing aids, with the company seeking to leverage its popular earbuds to become a slice of the growing hearing-aids space. The company is also working on new features for users to test their hearing.
- A digital, paid health coaching service remains in development. The company is discussing using artificial intelligence and data from user devices to craft individualized workout and eating plans for customers.
- The company is exploring anti-anxiety and workout features for its upcoming Vision Pro headset.
Read the full story from Bloomberg about Apple's health efforts, including how the work originated, development of a non-invasive glucose sensor, failed attempts at other tantalizing efforts and internal conflicts about choosing to focus on prevention rather than people who are already sick.Â
More stories like this are available on bloomberg.com
©2023 Bloomberg L.P.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
